课题基金 / 基金详情

PLASMA CATECHOLAMINES AND SYMPATHETIC ACTIVITY IN CLINICAL HYPERTENSION

PLASMA CATECHOLAMINES AND SYMPATHETIC ACTIVITY IN CLINICAL HYPERTENSION
临床高血压中的血浆儿茶酚胺和交感神经活动
批准号:
3966596
负责人:
D S GOLDSTEIN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

D S GOLDSTEIN的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have developed and applied methodology for measuring regional and total body release and neuronal uptake of norepinephrine (NE), the sympathetic neurotransmitter, and have assessed the effects of various stimuli (isoproterenol, clonidine, manipulations of dietary salt) on sympathetic activity. Total body spillover of NE into the circulation is increased by playing an electronic game, which also increases blood pressure, pulse rate, cardiac output, and forearm blood flow. Applying these methods to patients with essential hypertension should allow testing of the long-standing hypothesis that excessive sympathetic responses to mental challenge characterizes young patients with hypertension or subjects at risk for developing established hypertension. The clonidine suppression test can be conducted without controlling dietary salt intake and can be used to define the neurogenic contribution to hypertension. Isoproterenol stimulates NE release without affecting plasma epinephrine (E) and may therefore be helpful in studying pre-synaptic beta-adrenoceptor function in hypertensive patients. Circulating beta-adrenoceptor agonists do not increase adrenocorticotropin (ACTH).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot Projects - Autonomic Rare Diseases Clinical Research Consortium
  • 批准号:
    7901216
  • 项目类别:
  • 资助金额:
    $7.8万
  • 财政年份:
    2009
  • 负责人:
    D S GOLDSTEIN
  • 依托单位:
BIOCHEMICAL METHODS FOR VASOACTIVE SUBSTANCES
COLLABORATIVE STUDIES OF NEUROENDOCRINE PHARMACOLOGY AND PHYSIOLOGY
SYMPATHOADRENAL AND CATECHOLAMINERGIC FUNCTION IN HEALTH AND DISEASE